Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2019-04-27 | 2019-04-26 |
Drug Identification Number | 02247790 | 02247790 |
Brand name | REPRONEX | REPRONEX |
Common or Proper name | Menotropins for Injection | Menotropins for Injection |
Company Name | FERRING INC | FERRING INC |
Ingredients | MENOTROPINS | MENOTROPINS |
Strength(s) | 75UNIT | 75UNIT |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | Boxes 5 vials + 5x2 mL vials diluent | Boxes 5 vials + 5x2 mL vials diluent |
ATC code | G03GA | G03GA |
ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | ||
Actual discontinuation date | 2019-04-23 | 2019-04-23 |
Remaining supply date | 2019-04-23 | 2019-04-23 |
Discontinuation status | Discontinued | Discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | REPRONEX is discontinued. Alternate products are available by Ferring such as MENOPUR (Menotropins for injection) (75 IU FSH/ 75 IU LH). Please contact your healthcare professional. | REPRONEX is discontinued. Alternate products are available by Ferring such as MENOPUR (Menotropins for injection) (75 IU FSH/ 75 IU LH). Please contact your healthcare professional. |
Health Canada comments |